Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Therapeutic efficacy of antibo...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors

Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors

Bibliographic Details
Main Authors: Daniel V Kalinovsky, Alexey V Kibardin, Irina V Kholodenko, Elena V Svirshchevskaya, Igor I Doronin, Mariya V Konovalova, Maria V Grechikhina, Fedor N Rozov, Sergey S Larin, Sergey M Deyev, Roman V Kholodenko
Format: Article
Language:English
Published: BMJ Publishing Group 2022-06-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/10/6/e004646.full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://jitc.bmj.com/content/10/6/e004646.full

Similar Items

  • Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment–Drug Conjugates Carrying Maytansinoids DM1 and DM4
    by: Daniel V. Kalinovsky, et al.
    Published: (2023-10-01)
  • Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies
    by: Irina V. Kholodenko, et al.
    Published: (2019-10-01)
  • Neuroblastoma Origin and Therapeutic Targets for Immunotherapy
    by: Irina V. Kholodenko, et al.
    Published: (2018-01-01)
  • RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype
    by: Maxim Sorokin, et al.
    Published: (2020-05-01)
  • Resistance of Human Liver Mesenchymal Stem Cells to FAS-Induced Cell Death
    by: Irina V. Kholodenko, et al.
    Published: (2022-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs